肾肿块冷冻消融后即刻活检的诊断效能与临床结局验证
所有标本均具诊断性,3个月影像随访显示全部病灶完全缓解,中位随访1415天未见复发或针道种植。
要点
- 冷冻消融后即刻活检不影响消融病灶的完全影像学缓解。
- 消融后即刻取材所有标本均获得明确病理诊断,含多种肾细胞癌亚型。
- 中位随访1415天未见肿瘤复发或针道种植,提示操作安全性良好。
核心结论
- 冷冻消融后即刻肾肿块活检诊断可靠,在临床实践中可能提供获益。
研究设计与样本
- 操作由术者酌情决定,在主动或被动融冰并拔除探针后,经同轴针每灶至少取2条18G芯针活检标本。
- 标本经福尔马林固定后由病理科审阅,随访影像与实验室检查于3个月、6或9个月进行,之后每年复查。
关键影像表现/征象
- 所有病灶在3个月随访影像上均表现为完全影像学缓解。
诊断标准与关键数值
- 病理诊断包括肾细胞癌19例、嗜酸细胞瘤6例、后肾腺瘤1例。
- 肾细胞癌亚型包括透明细胞型、乳头状型、嫌色细胞型、肉瘤样及混合组织学类型。
临床应用与阅片要点
- 影像引导冷冻消融后即刻经同轴针取材可获得明确病理诊断,避免术前活检相关的出血与靶灶显示不清问题。
- 并发症仅限于术后即刻阶段,未观察到迟发不良事件或慢性后遗症。
局限性
- 单中心、回顾性设计,活检时机由术者酌情决定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Image-guided thermal ablation is a guideline-supported treatment for small renal tumors. While biopsy is recommended, the optimal timing relative to ablation remains undefined. Pre-ablation biopsy may complicate ablation through hemorrhage, impaired target visualization, and potential tumor seeding. Post-cryoablation biopsy has been described in a small cohort of patients, but reproducibility has not been established. This study evaluated the diagnostic performance and clinical outcomes of renal mass biopsy performed immediately after cryoablation in a single session.
METHODS: This retrospective, single-center study included patients who underwent image-guided percutaneous cryoablation followed by immediate post-ablation core needle biopsy, performed at operator discretion, between December 2018 and April 2025. After active or passive thaw and probe removal, at least two 18-gauge core biopsy samples were obtained per lesion using a coaxial needle. Specimens were formalin-fixed and reviewed by pathology. Outcomes included specimen adequacy, histopathologic diagnosis, adverse events, imaging response, and tumor recurrence or seeding. Follow-up imaging and labs were performed at 3 and 6 or 9 months, then annually.
RESULTS: Twenty-six solid enhancing renal masses (mean size 2.5 cm, range 1.4-4.7 cm) in 24 patients were included. All biopsy specimens were diagnostic with histologic diagnoses including renal cell carcinoma (RCC, n = 19), oncocytoma (n = 6), and metanephric adenoma (n = 1), with RCC subtypes including clear cell, papillary, chromophobe, sarcomatoid, and mixed histology. Complications were limited to the immediate post-procedural period, with no delayed adverse events or chronic sequelae. All lesions demonstrated complete radiographic response on 3-month follow-up imaging. There were no cases of tumor recurrence or seeding observed over a median follow-up of 1,415 days.
CONCLUSION: Immediate post-cryoablation renal mass biopsy is diagnostically reliable and may provide benefit in clinical practice.
引用
- Islam, Toskich, Thiel, et al. Immediate percutaneous renal mass biopsy following cryoablation: validation of diagnostic performance and clinical outcomes. Abdom Radiol (NY). 2026. PMID: 42322418. doi:10.1007/s00261-026-05577-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。